학술논문
OA14.04 Five-Year Outcomes From the Randomized, Phase 3 Trials CheckMate 017/057: Nivolumab vs Docetaxel in Previously Treated NSCLC
Document Type
Abstract
Author
Gettinger, S.; Borghaei, H.; Brahmer, J.; Chow, L.; Burgio, M.; De Castro Carpeno, J.; Pluzanski, A.; Arrieta, O.; Frontera, O. Aren; Chiari, R.; Butts, C.; Wojcik-Tomaszewska, J.; Coudert, B.; Garassino, M.; Ready, N.; Felip, E.; Garcia, M. Alonso; Waterhouse, D.; Domine, M.; Barlesi, F.; Antonia, S.; Wohlleber, M.; Gerber, D.; Czyzewicz, G.; Spigel, D.; Crino, L.; Eberhardt, W.; Li, A.; Marimuthu, S.; Vokes, E.
Source
In Journal of Thoracic Oncology October 2019 14(10) Supplement:S244-S245
Subject
Language
ISSN
1556-0864